na-931 vs retatrutide Biomed Industries presents Phase 2 results for NA-931, a new obesity treatment. | Biomed Industries Inc posted on the topic Xia & He Publishing
Description
The debate over compounded GLP-1s has played out in ad battles
When both groups took a glucose tolerance testthat is, when they drank a hefty dose of glucosetheir blood sugar levels didnt rise as much as it did when they entered the study
The injection site does not directly affect reflux, but subcutaneous injections in the abdomen versus the thigh can produce slightly different absorption rates, which might indirectly influence the timing of GI effects
The most promising signal in the current research involves binge eating, and it is worth taking seriously, with some important clinical nuance attached
Haba-Rubio, J
The score updates as you log data
